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Cytochrome P450s (CYPs) are an essential family of enzymes in the human body. They
play a crucial role in metabolism, especially in human steroid biosynthesis. Reactions
catalyzed by these enzymes are highly stereo- and regio-specific. Lack or severe
malfunctions of CYPs can cause severe diseases and even shorten life. Hence,
investigations on metabolic reactions and structural requirements of substrates are
crucial to gain further knowledge on the relevance of different enzymes in the human
body functions and the origin of diseases. One key enzyme in the biosynthesis of gluco-
and mineralocorticoids is CYP21A2, also known as steroid 21-hydroxylase. To investigate
the steric and regional requirements of substrates for this enzyme, we performed whole-
cell biotransformation assays using a strain of fission yeast Schizosaccharomyces pombe
recombinantly expressing CYP21A2. The progestogens progesterone, pregnenolone,
and their 17a-hydroxy-derivatives were used as substrates. After incubation, samples
were analyzed using gas chromatography coupled to mass spectrometry. For
progesterone and 17a-hydroxyprogesterone, their corresponding 21-hydroxylated
metabolites 11-deoxycorticosterone and 11-deoxycortisol were detected, while after
incubation of pregnenolone and 17a-hydroxypregnenolone, no hydroxylated product
was observed. Findings were confirmed with authentic reference material. Molecular
docking experiments agree with these results and suggest that interaction between the 3-
oxo group and arginine-234 of the enzyme is a strict requirement. The presented results
demonstrate once more that the presence of an oxo-group in position 3 of the steroid is
indispensable, while a 3-hydroxy group prevents hydroxylation in position C-21 by
CYP21A2. This knowledge may be transferred to other CYP21A2 substrates and
hence help to gain essential insights into steroid metabolism.
Keywords: corticosteroid, cytochrome P450, CYP21A2, GC-MS, fission yeast (Schizosaccharomyces pombe),
molecular docking, steroid biosynthesisn.org June 2021 | Volume 12 | Article 6337851
Loke et al. Corticosteroid Biosynthesis RevisitedINTRODUCTION
Cytochrome P450 enzymes (CYPs) are an important class of
enzymes in the human body. Acting mainly as hydroxylases,
they are responsible for a wide variety of metabolic reactions.
CYPs form a remarkably versatile enzyme superfamily that has
been found in all domains of life and already includes more
than 370,000 named members (1). In humans, there are 57
isoforms that can be subdivided by sequence homology into 18
families and 43 subfamilies. However, they may also be
categorized according to their subcellular localization, their
electron transport chains, or their biological functions (2, 3).
On the one hand, substances like xenobiotic drugs can be
excreted easier after CYP catalyzed hydroxylation; on the
other hand, they also play an essential role in the synthesis
of many endogenous compounds (4). Six of these enzymes are
reported to fulfill critical physiological functions in steroid
hormone biosynthesis, namely CYP11A1 (cytochrome
P450 scc , s ide-chain c leavage enzyme) , CYP17A1
(cytochrome P450 17a, steroid 17a-hydroxylase and 17,
20-lyase), CYP21A2 (cytochrome P450 c21, steroid
21-hydroxylase), CYP11B1 (cytochrome P450 11b, steroid
11b-hydroxylase), CYP11B2 (cytochrome P450 aldo,
aldosterone synthase) and CYP19A1 (cytochrome P450 aro,
aromatase) (5).
Steroidogenic CYPs display high substrate specificity, which
only allows a small group of substances with a defined structure
to be transformed. This regio- and stereospecific oxy
functionalization is of high biological relevance, and especially
CYPs involved in steroid biosynthesis have been considered to be
unable to metabolize xenobiotics. In the last decade, this
hypothesis, however, was demonstrated to be not correct (6–
10). Still, strict structural requirements for substrates have been
demonstrated. As recently reported, substrates of CYP21A2
require a 3-oxo functionality at the steroid A-ring to be
successfully hydroxylated at the side chain attached to the D-
ring (7).
CYP21A2 is an important enzyme in the biotransformation
of progestogens into corticosteroids. The enzyme converts the
endogenous progestogens progesterone (pregn-4-ene-3,20-
d ione , PRO) and 17a -hydroxyproges terone (17a -
hydroxypregn-4-ene-3,20-dione, 17aOH-progesterone, 17PRO)
to 11-deoxycorticosterone (21-hydroxypregn-4-ene-3,20-dione,
DOC) and 11-deoxycortisol (17a,21-dihydroxypregn-4-ene-
3,20-dione, RSS), respectively, by hydroxylation at the C-21
position (11). Therefore, it plays an essential role in the
biosynthesis of both gluco- and mineralocorticoids. Hence,
humans with reduced activity of CYP21A2 may suffer from
congenital adrenal hyperplasia (CAH), which is characterized by
decreased production of cortisol (12). Due to feedback
mechanisms of the hypothalamic-pituitary-adrenal axis,
increased concentrations of progestogens, but also of
androgens resulting from alternative metabolic pathways, are
observed in these patients (13).
Based on recent findings on substrate selectivity of human
CYP21A2, this work gives a deeper insight into the endogenous
compounds PRO, 17PRO, pregnenolone (PRE), and 17a-Frontiers in Endocrinology | www.frontiersin.org 2hydroxypregnenolone (17PRE). These substances have been
reported as substrates of the enzyme in the KEGG database
and by Cathro et al. (14). The data presented in this work help to
extrapolate findings to other potential substrates of CYP21A2
and may thus help to identify new metabolites or inhibitors of
the enzyme.MATERIALS AND METHODS
Chemicals and Reagents
The substrates PRO, PRE, 17PRO, and 17PRE as well as
the analytical references DOC and RSS, were obtained
from Steraloids Inc. (Newport, Rhode Island, USA). N-Methyl-
N-(trimethylsilyl)trifluoro acetamide (MSTFA) was purchased
from Chemische Fabrik Karl Bucher GmbH (Waldstetten,
Germany). All other chemicals and solvents were purchased
f r om App l iChem GmbH (Darms t ad t , Ge rmany ) ,
Merck (Darmstadt, Germany), Karl Roth (Karlsruhe,
Germany), Sigma Aldrich (Steinheim, Germany), Thermo
Fischer (Karlsruhe, Germany), or VWR International
(Darmstadt, Germany).
GC-MS Analyses
Gas chromatographic-mass spectrometric (GC–MS) analysis of the
samples was performed on an Agilent 7890A gas chromatographic
system coupled to an Agilent 5975 C inert mass selective detector
equipped with an Agilent HP1 column (17 m, 0.2 mm id, 0.11 mm
film thickness). The following parameters were used for the analysis
of products: carrier gas: helium, oven program: 183 °C, +3 °C/min
to 232 °C (rate 1), +40 °C/min to 310 °C (rate 2), hold for 2 min,
injection volume: 2 mL, split 16:1, injection temperature: 300 °C,
electron ionization (EI): 70 eV, full scan mode from m/z 40 to m/z
1000. Prior to GC–MS analysis the dried residues were
pertrimethylsilylated (TMS derivatives) by reaction with 100 mL
TMIS reagent (MSTFA/ammonium iodide/ethanethiol, 1000:2:3, v:
w:v) at 75 °C for 20 min.
Steroid 21-Hydroxylation Assay
All experiments were conducted using the recombinant fission
yeast strain CAD75. As reported earlier, it co-expresses the
recombinant human steroid 21-hydroxylase together with
human cytochrome P450 reductase (CPR) (genotype: h- ura4-
D.18 leu1:: pCAD1-hCPR/pNMT1-CYP21A2) (15). Whole-cell
biotransformation assays were performed as described before (7).
In brief, cells were cultured for three days at 30 °C on plates
containing 5 µM thiamin. Pre- and main cultures were prepared
in Edinburgh Minimal Medium (EMM) (8). Substrates, dissolved
in ethanol (PRO, PRE, 17PRO) or methanol/dimethyl sulfoxide
(1 + 1 v/v) (17PRE), were added in a concentration of 500 µM to
cell suspension of CAD75 fission yeast in EMM and incubated
for 72 h at 30 °C under mild agitation. The cofactor NADPH
(needed for the P450-dependent bioconversion) is provided by
the fission yeast cells itself in sufficient quantity (16). After
centrifugation and separation from the cell pellet, theJune 2021 | Volume 12 | Article 633785
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was dried, and product analysis was performed by GC-MS after
trimethylsilyl-derivatization, as described in the section GC-
MS Analyses.
Molecular Modeling
Molecular docking experiments were performed using GOLD
software [Genetic Optimisation for Ligand Docking, The
Cambridge Crystallographic Data Centre, UK (17, 18) v.5.2]
with 10 genetic algorithm (GA) runs. 3D starting geometries for
substrates PRE, 17PRO, and 17PRE were obtained with CORINA
[3D Structure Generator CORINA Classic, Molecular Networks
GmbH, Nuremberg, Germany (19)]. The X-ray structure of
CYP21A2 co-crystallized with PRO [PDB: 4Y8W (20)] served as
protein conformation. The binding pocket was defined by a sphere
of 12 Å radius with the C-8 atom of PRO as its center. GOLD was
executed with standard settings, besides setting search efficiency to
200% and enabling the ‘Generate diverse solutions’ option. KeyFrontiers in Endocrinology | www.frontiersin.org 3binding site residue Arg234 was marginally rotated during its
energy minimization conducted in the MOE software package
(Molecular Operating Environment 2019.01; Chemical
Computing Group ULC, Montreal, Canada) to allow for optimal
hydrogen bonding to 17PRE. This Arg234 orientation was kept for
all other compounds. Subsequently, energy minimization of and
3D pharmacophore modeling for the obtained poses was
conducted in LigandScout (21, 22) v.4.2. using the MMFF94
force field (23).RESULTS
Steroid 21-Hydroxylation Assay
The substrates PRO, PRE, 17PRO, and 17PRE, were incubated
with steroid 21-hydroxylase in a whole-cell biotransformation




FIGURE 1 | Mass spectra (GC-EI-MS) of the TMS derivatives of pregnenolone (A), 17a-hydroxypregnenolone (B), progesterone (C), 17a-hydroxyprogesterone
(D), 11-deoxycorticosterone (E), 11-deoxycortisol (F); abscissa: m/z, ordinate. intensity normalized to the highest peak.June 2021 | Volume 12 | Article 633785
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products of PRO and 17PRO. The product of PRO showed
peaks at m/z 546 and a loss of 245, the product of 17PRO
showed an abundant peak at m/z 544 and a subsequent loss of
311. The corresponding mass spectra of the TMS derivatives
are presented in Figures 1E, F. Additionally, peaks of the
remaining substrate were present in the chromatograms as
well (mass spectra in Figures 1C, D). Product structures were
deduced from the mass spectra from fragmentation analysis
and later confirmed by comparison with an authentic
reference material of DOC and RSS analyzed by GC-MS in
parallel. Similar retention times and characteristic fragment
ions were obtained for both, reference and products
of hydroxylation.Frontiers in Endocrinology | www.frontiersin.org 4In contrast, no hydroxylated substrate was detectable after
incubation of PRE or 17PRE. Mass spectra of substrates
are displayed in Figures 1A, B. Comparison of the
chromatograms revealed no product formation for these two
substrates. The chromatograms of the incubated substances in
comparison with the authentic reference material are
displayed in Figure 2. As reported earlier, multiple peaks
may be detected for one analyte due to the formation of
derivatization isomers (24).
Modeling Binding of 17PRO, PRE and
17PRE to Steroid 21-Hydroxylase
In order to rationalize the observed differences in the 21-
hydroxylation activity of CYP21A2, docking experiments forFIGURE 2 | Upper two rows: Chromatograms (GC-EI-MS) of the TMS derivatives of progesterone (PRO), 17-hydroxyprogesterone (17PRO), and their hydroxylated
products after incubation in comparison to the authentic reference material (due to the formation of derivatization isomers, multiple peaks are obtained for one
analyte). Lower two rows: Chromatograms (GC-EI-MS) of the TMS derivatives of pregnenolone (PRE) and 17-hydroxypregnenolone (17PRE) after incubation in
comparison to the authentic reference material (due to the formation of derivatization isomers, multiple peaks are obtained for one analyte).June 2021 | Volume 12 | Article 633785
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structure of CYP21A2 co-crystallized with PRO [PDB: 4Y8W
(20), Figure 3]. The catalytically competent binding mode of
PRO present in the X-ray structure places the C-21 atom 4 Å
away from the heme iron. The hydrogen bond of Arg234 and the
oxo group at C-3 of the substrate is critical to catalytically
competent binding (7) (Figure 3A). According to the
pharmacophore model the substrate methyl groups of PRO
and 17PRO form hydrophobic contacts to the active site of
CYP21A2. The key hydrogen bond to Arg234 is also present in
the pharmacophore model of the most plausible docking pose of
17PRO, which is highly similar to the orientation of PRO (Figure
3B). The C-21 atoms of PRO and 17PRO are in a highly similar
position (4 Å away from the heme) and hence the 17PRO pose is
deemed catalytically competent as well.
In contrast, the most plausible docking poses of PRE and
17PRE corresponding to catalytically competent orientation do
not involve hydrogen bonding to key residue Arg234 (Figures
3C, D), because the hydroxy groups at C3 represent only very
weak hydrogen bond acceptor properties. We suggest that these
orientations and productive binding of PRE or 17PRE to steroid
21-hydroxylase (CYP21A2) does not occur in vivo. Hence, we
further suggest that conversion of PRE and 17PRE to 21-Frontiers in Endocrinology | www.frontiersin.org 5hydroxypregnenolone (T) and 17, 21-dihydroxypregnenolone
(R), respectively, is highly unlikely.DISCUSSION
As expected, PRO and 17PRO are substrates for 21-
hydroxylation catalyzed by human CYP21A2 (Figure 4A). The
resulting products were confirmed as DOC and RSS by GC-MS
comparison with authentic reference material [confidence
level 1, according to Schymanski et al. (25)]. GC-MS analysis
showed a characteristic loss of 245 for DOC corresponding to a
fragment of the hydroxylated D-ring (Figure 1E). For RSS, no
peak for the molecular ion (m/z 634) could be detected (Figure
1F). However, a signal with m/z 544 was observed, which is
identified as [M-90]+ (a loss of TMSOH), and a subsequent loss
of 311, resulting in a fragment with m/z 233, which is caused by
B/C-ring fragmentation.
The rates of successful hydroxylation in the assays were
calculated by comparison of the areas in the GC-
chromatograms. After 72 h PRO was hydroxylated to 92%,
17PRO was hydroxylated to over 99%. In a previous
publication the product space-time yields for the conversion ofA B
DC
FIGURE 3 | Substrate binding to the active site of CYP21A2. Progesterone binding mode from X-ray structure (PDB: 4Y8W) (A, PRO). Suggested binding modes of
17a-hydroxyprogesterone (B, 17PRO), pregnenolone (C, PRE) and 17a-hydroxypregnenolone (D, 17PRE) obtained from docking. Active substrates (A, B) form the
key interaction to Arg234. Inactive substrates (C, D) do not show this interaction, which makes productive binding highly unlikely.June 2021 | Volume 12 | Article 633785
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by whole-cell biotransformation with strain CAD75 were
reported (15). The absence of any signal for potential products
of hydroxylation in case of PRE and 17PRE substantiates the
hypothesis of no hydroxylation in the latter cases.
These results are in line with common knowledge of steroid
biosynthesis, where the progestogens PRO and 17PRO are
converted to corticoids (5) by 21-hydroxylation. Similarly,
Lattemann et al. (26) reported the successful 21-hydroxylation
of 3-keto steroids in whole-cell biotransformation utilizing
human CYP21A2 recombinantly expressed in E. coli. They
disclosed the successful conversion of natural and non-natural
steroid substrates, all showing a 3-oxo group. As demonstrated in
earlier experiments, the A-ring composition of CYP21A2-
substrates plays a crucial role in hydroxylation. It was
demonstrated that the 3-oxo group is a strict prerequisite for
CYP21A2 substrates (7). In line with these findings, the
incubation of endogenous 3-hydroxy steroids PRE and 17PRE
did not lead to their 21-hydroxylated analogs (Figure 4B).
No signals corresponding to hydroxylated metabolites of PRE
or 17PRE were detected following their incubation with
CYP21A2. Molecular docking experiments supported the
structure requirements. Interaction of the carbonyl group at C-
3 of the substrate to the side-chain Arg234 of the enzyme
is indispensable.Frontiers in Endocrinology | www.frontiersin.org 6In contrast, earlier reports from literature postulate the 21-
hydroxylation of PRE based on in vitro experiments utilizing
adrenal microsomes (27). Human adrenal microsomes yielded R
after incubation of PRE in their assay. Already reported in the
1960s, PRE is transformed into PRO prior to 21-hydroxylation
(28). Significant amounts of T in vivo are reported in newborn
infants (day 0-3 after delivery) or adult males after
corticotrophin stimulation, while generally only small amounts
of T were detected in adult humans (29, 30). Cathro et al. thus
postulated the direct 21-hydroxylation as a subsidiary pathway in
humans (30). Furthermore, Cathro et al. (14) postulated the
direct 21-hydroxylation of PRE, while 17PRE is reported to
undergo side-chain cleavage to yield dehydroepiandrosterone
(DHEA). However, in 1980 Kaufmann et al. hypothesized that
alternative pathways of corticosteroid biosynthesis exist. As
postulated, T, and R are most likely generated via 21-hydroxy-
or 17,21-dihydroxydesmosterol involving adrenocorticotropin
(ACTH) rather than direct hydroxylation of PRE or 17PRE
(31). According to our results we consider it likely that also the
21-hydroxylation of desmosterol is not catalyzed by steroid
21-hydroxylase in humans (Figure 5). The presented results
hence help to better understand corticoid formation and may
thereby provide important basic knowledge for the treatment of
diseases that are linked to enzyme deficiencies involved in
corticoid biosynthesis.A
B
FIGURE 4 | A-ring structure dependent hydroxylation of progestogens (A) successful hydroxylation of 3-keto steroids (R = H = progesterone; R = OH = 17a-
hydroxyprogesterone), (B) no hydroxylation of 3-hydroxy steroids (R = H = pregnenolone; R = OH = 17a-hydroxypregnenolone).June 2021 | Volume 12 | Article 633785
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